Posters for 2026 britMODIS

Introduction There are few data on Parkinson’s disease (PD) in Africa, particularly in sub-Saharan Africa (SSA). The NIHR Global Health Research Group Transforming Parkinson’s Care in Africa (TraPCAf) is a four-year study, running from September 2022, investigating PD in seven African countries (1). In SSA, hypertension is highly prevalent, with many individuals remaining undiagnosed and, among those diagnosed, many untreated or poorly controlled (2). Method The TraPCAf project is recruiting a target of 1,000 people with PD (PwP) and 2,000 age- and sex-matched healthy controls. Data collected

Objective: Guidelines recommend use of rotigotine patches as an option if Parkinson’s patients are unable to take their usual oral medication, but this strategy has not been tested in clinical trials. We audited outcomes for such patients in a large UK teaching hospital. Background: This project was undertaken at University Hospitals of Derby and Burton. Method: In this retrospective study, data was extracted from the hospital’s electronic prescribing and medication administration system, Lorenzo. We examined data on every hospitalised Parkinson’s patient prescribed rotigotine at Royal Derby

Introduction: The Lewy Body Dementias (LBD) incorporate both Parkinson’s Disease Dementia (PDD) and Dementia with Lewy Bodies (DLB). These conditions have a heterogeneous presentation and disease trajectory with much inter-individual variability. Accurate diagnostics and prognostication are becoming increasingly important in the potential disease modifying era. Cardiovascular autonomic dysfunction is a supportive diagnostic feature of DLB and a well-known non-motor phenotype of Parkinson’s Disease. It most commonly presents with orthostatic hypotension (OH) which can be easily measure